{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:36:41Z","timestamp":1783355801395,"version":"3.54.6"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"crossref","award":["81560387"],"award-info":[{"award-number":["81560387"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"crossref","award":["81902983"],"award-info":[{"award-number":["81902983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"guangxi natural science foundation of china","award":["2018JJB140382"],"award-info":[{"award-number":["2018JJB140382"]}]},{"name":"\u201cmedical excellence award\u201d funded by the creative research development grant from the first affiliated hospital of guangxi medical university","award":["180327"],"award-info":[{"award-number":["180327"]}]},{"name":"guangxi medical and health technology development and application project","award":["S2019097"],"award-info":[{"award-number":["S2019097"]}]},{"name":"guangxi medical and health technology development and application project","award":["S2018100"],"award-info":[{"award-number":["S2018100"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The number of patients with hepatocellular carcinoma (HCC) is showing a growing trend all over the world. The metabolic microenvironment has been shown to play a key role in the pathogenesis of HCC in recent studies. The expression of metabolites and metabolic processes in tumor cells can be regulated by gene regulation mediated by long non-coding RNAs (lncRNAs), the abnormal expression of which is closely related to tumor occurrence and metastasis. However, the fundamental mechanism of applying metabolism-related lncRNAs to predicting HCC is still unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>With the complete RNA sequence data and clinical data obtained from The Cancer Genome Atlas database and metabolism-related genes downloaded from the Kyoto Encyclopedia of Genes and Genomes database, with false discovery rate\u200a&lt;\u200a0.001, log fold change\u200a&gt;\u200a1.5 selected as the screening criteria for lncRNA, the relationship between the expression level of metabolism-related LncRNAs (MRLs) and the overall survival rate was determined by the Univariate Cox regression analyses with the establishment of the metabolic prognosis model by the application of Multivariate Cox regression analyses, revealing the different biological processes and signaling pathways in both high-risk groups and low-risk groups by Gene Ontology, Kyoto Encyclopedia of Genes and Genomes enrichment analysis, and gene set enrichment analysis, leading the expression of lncRNA to be assessed by the reverse transcription-polymerase chain reaction results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The overall survival rate of HCC patients is significantly correlated with signature of 5-MRLs. The prognosis characteristics of lncRNA reveal the relatively high death rate of patients in the high-risk groups, with the predicted signals by functional and pathway enrichment analysis related to biosynthesis, metabolic process, and metabolic pathway, with the prognostic characteristics of 5-MRLs by the combined analysis showing that it is an independent factor of HCC superior to the traditional clinical indicators in predicting the prognosis. A trend of high-expression was shown in MRLs in tumors by reverse transcription-polymerase chain reaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The new 5-MRLs as potential biomarkers provide more powerful prognostic information for HCC patients. In the future clinical treatment of HCC, it will provide doctors with more methods.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028694","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T14:05:18Z","timestamp":1643378718000},"page":"e28694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Bioinformatics analysis and experimental verification of five metabolism-related lncRNAs as prognostic models for hepatocellular carcinoma"],"prefix":"10.1097","volume":"101","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongrui","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banghao","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","author":"Liver","year":"2018","journal-title":"J Hepatol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3322\/caac.21695","article-title":"Cancer statistics for the US Hispanic\/Latino population, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2018\/7512159","article-title":"Aberrant metabolism in hepatocellular carcinoma provides diagnostic and therapeutic opportunities","volume":"2018","author":"De Matteis","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"R7-20250504","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061668","article-title":"Glucose metabolism and oxidative stress in hepatocellular carcinoma: role and possible implications in novel therapeutic strategies","volume":"12","author":"Mossenta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R8-20250504","first-page":"31","article-title":"Cancer metabolism: a novel perspective on precision diagnosis and treatment for liver cancer","volume":"58","author":"Ning","year":"2020","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"R9-20250504","first-page":"17261","article-title":"A six-microRNA set as prognostic indicators for bile duct cancer","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2019\/2408348","article-title":"Mining TCGA Database for tumor microenvironment-related genes of prognostic value in hepatocellular carcinoma","volume":"2019","author":"Deng","year":"2019","journal-title":"Biomed Res Int"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/EDE.0000000000000004","article-title":"Prognostic ROC curves: a method for representing the overall discriminative capacity of binary markers with right-censored time-to-event endpoints","volume":"25","author":"Combescure","year":"2014","journal-title":"Epidemiology"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1477-2574.2010.00207.x","article-title":"Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma","volume":"12","author":"Wu","year":"2010","journal-title":"HPB"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1021\/pr300502v","article-title":"Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry","volume":"11","author":"Ye","year":"2012","journal-title":"J Proteome Res"},{"key":"R15-20250504","first-page":"a028589","article-title":"Cytokines and long noncoding RNAs","volume":"10","author":"Susan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R16-20250504","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.R116.760884","article-title":"LncRNAs and their transcriptional control of inflammatory responses","volume":"292","author":"Mathy","year":"2017","journal-title":"J Biol Chem"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","article-title":"A long noncoding RNA activated by TGF-\u03b2 promotes the invasion-metastasis cascade in hepatocellular carcinoma","volume":"25","author":"Yuan","year":"2014","journal-title":"Cancer Cell"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.18632\/oncotarget.2934","article-title":"Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"415.e18","DOI":"10.1053\/j.gastro.2014.10.012","article-title":"The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of \u03b2-Catenin in HCC cells","volume":"148","author":"Cao","year":"2015","journal-title":"Gastroenterology"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/hep.28393","article-title":"Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.lfs.2018.02.006","article-title":"LncRNA FAL1 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells","volume":"197","author":"Li","year":"2018","journal-title":"Life Sci"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gene.2018.10.058","article-title":"LncRNA LINC00460 promotes tumor growth of human lung adenocarcinoma by targeting miR-302c-5p\/FOXA1 axis","volume":"685","author":"Ye","year":"2019","journal-title":"Gene"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"679","DOI":"10.5114\/aoms.2017.69147","article-title":"High lncRNA HULC expression is associated with poor prognosis and promotes tumor progression by regulating epithelial-mesenchymal transition in prostate cancer","volume":"14","author":"Zheng","year":"2018","journal-title":"Arch Med Sci"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1007\/s11033-020-05521-4","article-title":"MicroRNA signature in hepatocellular carcinoma patients: identification of potential markers","volume":"47","author":"Elhendawy","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/ijc.25881","article-title":"Salivary metabolite signatures of oral cancer and leukoplakia","volume":"129","author":"Wei","year":"2011","journal-title":"Int J Cancer"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/rcm.3708","article-title":"A serum metabolomic investigation on hepatocellular carcinoma patients by chemical derivatization followed by gas chromatography\/mass spectrometry","volume":"22","author":"Xue","year":"2008","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/hep.26130","article-title":"Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma","volume":"57","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/hep.26350","article-title":"Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification","volume":"58","author":"Beyo\u011flu","year":"2013","journal-title":"Hepatology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2016.04.039","article-title":"Integrative functional genomic analysis unveils the differing dysregulated metabolic processes across hepatocellular carcinoma stages","volume":"588","author":"Ramesh","year":"2016","journal-title":"Gene"},{"key":"R31-20250504","article-title":"Lipid metabolism in development and progression of hepatocellular carcinoma","volume":"126","author":"Sangineto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-018-0838-5","article-title":"Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation","volume":"17","author":"Liu","year":"2018","journal-title":"Mol Cancer"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1158\/0008-5472.CAN-14-1192","article-title":"Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway","volume":"75","author":"Cui","year":"2015","journal-title":"Cancer Res"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7150\/thno.28992","article-title":"LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt\/mTOR Signaling pathway","volume":"9","author":"Zheng","year":"2019","journal-title":"Theranostics"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/oncsis.2017.81","article-title":"Xanthine dehydrogenase downregulation promotes TGF\u03b2 signaling and cancer stem cell-related gene expression in hepatocellular carcinoma","volume":"6","author":"Chen","year":"2017","journal-title":"Oncogenesis"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.biopha.2018.12.134","article-title":"MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma","volume":"111","author":"Wang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"R38-20250504","first-page":"1107","article-title":"Integral analyses of survival-related long non-coding RNA MIR210HG and its prognostic role in colon cancer","volume":"18","author":"Ruan","year":"2019","journal-title":"Oncol Lett"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"e0160451","DOI":"10.1371\/journal.pone.0160451","article-title":"Long Noncoding RNA miR210HG as a potential biomarker for the diagnosis of glioma","volume":"11","author":"Min","year":"2016","journal-title":"PLoS One"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.15403\/jgld-356","article-title":"Clinical value of lncRNA LUCAT1 expression in liver cancer and its potential pathways","volume":"28","author":"Jiao","year":"2019","journal-title":"J Gastrointestin Liver Dis"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","article-title":"Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e20422","DOI":"10.1097\/MD.0000000000020422","article-title":"Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma","volume":"99","author":"Deng","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:27:45Z","timestamp":1746332865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028694","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"assertion":[{"value":"2021-07-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}